Technology

Intensity Therapeutics, Inc. Rings the Nasdaq Stock Market Closing Bell

Published

Intensity Therapeutics, Inc. (Nasdaq: INTS), a late-stage clinical biotechnology company developing new and exciting approach to treat cancer with results from over 200 patients and partnerships with major pharmaceutical companies visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Lewis H. Bender, Founder, President, and CEO, rings the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now